University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Endotracheal Tube Holder and Bite Guard Research

Phase 4

Completed

Conditions: Surgery
Anesthesia

Interventions: Device: Haider ETT Tube Holder and Bite Guard
Procedure: Tape

First Posted Date: 2015-01-27

Last Posted Date: 2017-04-17

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT02347488

Locations: 🇺🇸
University of California, Los Angeles, California, United States

Improving Bladder Function in SCI by Neuromodulation

Not Applicable

Recruiting

Conditions: Spinal Cord Injury

Interventions: Device: Electromagnetic Neuromodulation

First Posted Date: 2015-01-06

Last Posted Date: 2023-05-19

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 24

Registration Number: NCT02331979

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients

Phase 4

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: tofacitinib 5mg po bid

First Posted Date: 2014-12-22

Last Posted Date: 2019-03-19

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 37

Registration Number: NCT02321930

Locations: 🇺🇸
UCLA David Geffen School of Medicine, Division of Rheumatology, Los Angeles, California, United States

A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis

Phase 2

Withdrawn

Conditions: Multiple Sclerosis

Interventions: Drug: placebo gel
Drug: testosterone

First Posted Date: 2014-12-15

Last Posted Date: 2016-08-04

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT02317263

Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II

Phase 3

Withdrawn

Conditions: Mild Cognitive Impairment

Interventions: Procedure: Amyloid imaging
Procedure: FDG-PET

First Posted Date: 2014-12-15

Last Posted Date: 2018-10-15

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT02317250

Augmentation of Cognitive Training in Children With TBI With D-Cyloserine

Early Phase 1

Conditions: Traumatic Brain Injury

Interventions: Behavioral: Cogmed Working Memory Training
Drug: D-Cycloserine

First Posted Date: 2014-12-09

Last Posted Date: 2014-12-09

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT02312635

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Spinal Cord Neuromodulation for Spinal Cord Injury

Phase 1

Active, not recruiting

Conditions: Tetraparesis
Tetraplegia
Cervical Spinal Cord Injury

Interventions: Device: Epidural Stimulation
Drug: Buspirone

First Posted Date: 2014-12-09

Last Posted Date: 2023-05-19

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 12

Registration Number: NCT02313194

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Effectiveness of Peer Navigation and Contingency Management on Retention in HIV Care

Not Applicable

Completed

Conditions: HIV/AIDS

Interventions: Behavioral: Contingency Management
Behavioral: Peer Navigation
Behavioral: Combined Contingency Management and Peer Navigation

First Posted Date: 2014-12-08

Last Posted Date: 2020-11-17

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 579

Registration Number: NCT02310893

Locations: 🇺🇸
Center for Health Justice, Los Angeles, California, United States
🇺🇸
Los Angeles Sheriff's Department, Los Angeles, California, United States
🇺🇸
AltaMed Health Services Corporation, Los Angeles, California, United States

and more 3 locations

Trial to Reduce Hospitalizations in Children With Medical Complexity

Phase 2

Completed

Conditions: Chronic Illness

Interventions: Behavioral: Routine Care
Behavioral: Plans of Action and Care Transitions

First Posted Date: 2014-10-29

Last Posted Date: 2017-10-26

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 200

Registration Number: NCT02277327

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion

Not Applicable

Completed

Conditions: Abortion, Induced

Interventions: Drug: Digoxin (transvaginal administration)
Drug: Digoxin (transabdominal administration)

First Posted Date: 2014-10-28

Last Posted Date: 2017-01-13

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 60

Registration Number: NCT02277249

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy